Andy Bader
Company: Trimuvira Immunologics
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Discuss the Strengths of Immunological Approaches to Tumor Killing in HER2+ Approaches 11:30 am
For full session details, download the full event guideRead more
day: Conference Day Two
Novel Approach to Treatment of HER2 Gastric Cancers – Recent Data Release & the Perspective for Improving the Patient Experience 1:00 pm
For full session details, download the full event guideRead more
day: Conference Day Two